PAYER POLICY CHANGES

S3861 Insurance Policy Changes

HCPCS S3861 is officially defined as "Genetic testing, sodium channel, voltage-gated, type v, alpha subunit (scn5a) and variants for suspected brugada syndrome." HCPCS S3861 is referenced in 2 tracked payer policy changes from Blue Cross & Blue Shield of Mississippi and Excellus BlueCross BlueShield. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS S3861 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Watch S3861

Get one email when a payer policy names S3861, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

See every payer rule for S3861

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for S3861 in one place.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.